The PTEN-induced putative kinase 1 (PINK1)/Parkin pathway can tag damaged mitochondria and trigger their degradation by mitophagy. Before the onset of mitophagy, the pathway blocks mitochondrial motility by causing Miro degradation. PINK1 activates Parkin by phosphorylating both Parkin and ubiquitin. PINK1, however, has other mitochondrial substrates, including Miro (also called RhoT1 and -2), although the significance of those substrates is less clear. We show that mimicking PINK1 phosphorylation of Miro on S156 promoted the interaction of Parkin with Miro, stimulated Miro ubiquitination and degradation, recruited Parkin to the mitochondria, and via Parkin arrested axonal transport of mitochondria. Although Miro S156E promoted Parkin recruitment it was insufficient to trigger mitophagy in the absence of broader PINK1 action. In contrast, mimicking phosphorylation of Miro on T298/T299 inhibited PINK1-induced Miro ubiquitination, Parkin recruitment, and Parkin-dependent mitochondrial arrest. The effects of the T298E/T299E phosphomimetic were dominant over S156E substitution. We propose that the status of Miro phosphorylation influences the decision to undergo Parkin-dependent mitochondrial arrest, which, in the context of PINK1 action on other substrates, can restrict mitochondrial dynamics before mitophagy.
The PTEN-induced putative kinase 1 (PINK1)/Parkin pathway can tag damaged mitochondria and trigger their degradation by mitophagy. Before the onset of mitophagy, the pathway blocks mitochondrial motility by causing Miro degradation. PINK1 activates Parkin by phosphorylating both Parkin and ubiquitin. PINK1, however, has other mitochondrial substrates, including Miro (also called RhoT1 and -2), although the significance of those substrates is less clear. We show that mimicking PINK1 phosphorylation of Miro on S156 promoted the interaction of Parkin with Miro, stimulated Miro ubiquitination and degradation, recruited Parkin to the mitochondria, and via Parkin arrested axonal transport of mitochondria. Although Miro S156E promoted Parkin recruitment it was insufficient to trigger mitophagy in the absence of broader PINK1 action. In contrast, mimicking phosphorylation of Miro on T298/T299 inhibited PINK1-induced Miro ubiquitination, Parkin recruitment, and Parkin-dependent mitochondrial arrest. The effects of the T298E/T299E phosphomimetic were dominant over S156E substitution. We propose that the status of Miro phosphorylation influences the decision to undergo Parkin-dependent mitochondrial arrest, which, in the context of PINK1 action on other substrates, can restrict mitochondrial dynamics before mitophagy.
PINK1 | Parkin | Miro | mitochondrial transport | mitophagy P arkinson's disease (PD) is the second most common neurodegenerative disorder, and is closely linked to mitochondrial dysfunction (1, 2) . Two hereditary forms of recessive PD are caused by mutations in PINK1 (PTEN-induced putative kinase 1), a Ser/Thr mitochondrial kinase, and Parkin, a cytosolic E3 ubiquitin ligase (3, 4) . The realization that these proteins are in a single pathway, with PINK1 acting upstream of Parkin to influence mitochondrial properties, was a critical step in uncovering the underlying pathological mechanisms of PD (5) (6) (7) . This pathway can trigger the selective autophagy of damaged mitochondria, termed mitophagy (8, 9) , but additional cellular functions have also been indicated for PINK1 and Parkin (10) (11) (12) (13) (14) (15) . Much, however, remains unclear about how the PINK1/Parkin pathway is regulated.
In current models of PINK1/Parkin mitophagy (reviewed in ref. 1) , healthy mitochondria import a PINK1 precursor constitutively to the inner membrane, where it is cleaved (16) (17) (18) . The cleaved form then returns to the cytoplasm and is degraded by the N-end rule pathway (19) . Mitochondrial depolarization, or protein misfolding in the matrix of energized mitochondria (20) , prevent the import and degradation of PINK1, resulting in the accumulation of PINK1 on the outer mitochondrial membrane (OMM) (9, 21, 22) . Once on the OMM, PINK1 kinase activity recruits Parkin from the cytosol (8, 9) . Although Parkin adopts a self-inhibited conformation in solution (23) (24) (25) , it becomes fully activated in a PINK1-dependent manner on the mitochondria (9, 21) . Parkin ubiquitinates numerous proteins of the OMM (26, 27) , and thereby recruits autophagy-related proteins to the damaged mitochondrion for autophagosome assembly (28) (29) (30) .
How PINK1 recruits and activates Parkin on mitochondria remains incompletely understood, but two key components have been identified: PINK1 phosphorylation of both Parkin and ubiquitin (31) (32) (33) (34) . Together, these actions form a positive-feedback loop in which PINK1 activates Parkin by phosphorylating Serine 65. Activated Parkin adds ubiquitin to outer membrane-localized proteins at the mitochondrial surface, providing more substrates for PINK1 and the resulting phosphoubiquitin is an allosteric activator of Parkin, further increasing its activity. Recruitment and activation of Parkin, although distinct processes, are thus tightly linked (35, 36) by the positive feed-forward effect of ubiquitination by Parkin causing additional binding sites for Parkin, and additional binding causing further ubiquitination and allosteric activation of Parkin. Parkin substrates can also be de-ubiquitinated by Usp30 (37) and Usp15 (38) .
PINK1, however, can phosphorylate other proteins, including the motor-adaptor protein Miro (also called RhoT1/2), Mitofusin 1/2, and Hsp75 (also known as Trap1) (15, (39) (40) (41) (42) , and the functional role of those modifications in regulating Parkin is unclear. Given that some of these proteins are also substrates of Parkin (15, 39) , it is possible that modification of these proteins can act as a layer of regulation to modulate the overall levels of Parkin on mitochondria or to modulate specific aspects of mitochondrial dynamics, such as motility and fusion. Miro, an OMM GTPase involved in the regulation of mitochondrial traffic, is a well-established substrate of Parkin (15, 27, 43, 44) . Data from our laboratory and others indicated that PINK1 can interact with Miro and cause Miro phosphorylation of S156 in vitro (15, 45) . PINK1 and Parkin-mediated modifications of Miro result in the proteasomal degradation of Miro and, because Miro is required to tether kinesin and dynein to the mitochondrial surface, its degradation arrests mitochondrial movement. Genetic analysis indicated that, as in the mitophagic pathway, PINK1 acts upstream of Parkin in regulating motility (15) . The arrest of mitochondrial movement may be a precursor to mitophagy or, independent of mitophagy, provide a means of regulating mitochondrial dynamics. In Drosophila axons, for example, knockdown of
Significance
In mitophagy, damaged mitochondria stabilize PTEN-induced putative kinase 1 (PINK1) and recruit Parkin, an E3-ligase that ubiquitinates proteins on the outer membrane and targets mitochondria for degradation. The crucial roles of PINK1 phosphorylation of Parkin and ubiquitin in mitophagy are wellestablished. Other substrates of PINK1, however, have also been reported but the significance of those phosphorylations is less clear. We now show that Miro phosphorylations can regulate Parkin recruitment to Miro and trigger Miro degradation. The consequence of this branch of the PINK1/Parkin pathway is the disruption of mitochondrial motility, an event that may spatially restrict the deleterious effects of mitochondrial damage prior to the mitophagic removal of the organelle.
either PINK1 or Parkin increased mitochondrial transport in the absence of acute damage to the organelles (15) . Moreover, Miro phosphorylations are needed for the survival of dopaminergic neurons and the proper development of the neuromuscular junction in Drosophila (46) . Miro is thus a good candidate in which to explore the functional roles of PINK1 phosphorylations of Parkin substrates.
Previous experiments indicated that PINK1 can phosphorylate Miro in vitro not only on S156 but also on T298/299 (15) . We generated phosphomimetic and nonphosphorylatable Miro mutants in all three sites. Mimicking phosphorylation on S156 stimulated the interaction of Miro with Parkin, promoted the recruitment of Parkin to the mitochondria, and induced mitochondrial arrest in axons, but was not sufficient alone to trigger mitophagy. Mimicking T298/T299 phosphorylation suppressed the effects of the phosphomimetic S156E. We conclude that Miro phosphorylations on S156 and T298/T299 can regulate the onset of Parkin signaling by modulating the levels of Parkin on mitochondria and can regulate mitochondrial motility.
Results

Phosphomimetic Mutant MiroS156E Enhances the Recruitment of
Parkin to Mitochondria in a PINK1-Independent Manner. Mass spectrometry of recombinant Drosophila Miro phosphorylated in vitro by human PINK1 immunoprecipitated from HEK293T cells previously revealed two phospho-peptides, corresponding to amino acids 177-190 and 319-330 (15) . The homologous peptides in human Miro1 (hMiro1) contained the conserved sites S156, T298, and T299. To establish the likely consequences of the S156 modifications at the cellular level, we asked whether expressing the phosphomimetic MiroS156E influenced Parkin recruitment to mitochondria and its consequent arrest of mitochondrial motility. The phosphomimetic substitution per se did not detectably disrupt Miro function. Myc-MiroS156E coprecipitated with Xpress-tagged Milton equivalently to Myc-Miro when expressed in HEK293T (Fig. S1A) . In addition, when expressed in neurons, the MiroS156E construct correctly localized to axonal mitochondria (Fig. S1B) . Because overexpression of Miro constructs probably does not displace the endogenous Miro but increases Miro levels on mitochondria, we used overexpressed wild-type Miro as a control for phosphorylation-independent effects of Miro. If Miro phosphorylation can recruit and activate Parkin, we anticipated that the phosphomimetic Miro would have a dominant effect over the endogenous Miro. To determine if the S156E mutation altered Parkin distribution, YFP-Parkin was cotransfected into primary rat embryonic fibroblasts with either mock DNA, Myc-Miro, or MycMiroS156E and the abundance of YFP-Parkin in cytoplasmic and mitochondrial compartments was evaluated automatically in a blinded fashion using Mitolyzer1.0, a script we developed for ImageJ (Materials and Methods) ( Fig. 1 A and B) . In the absence of Miro overexpression, YFP-Parkin was not noticeably concentrated on mitochondria. Miro and MiroS156E isoforms were expressed at equivalent levels judged by α-Myc immunofluorescence levels ( Fig.  S1C ) and highly localized to mitochondria (Fig. 1A) . Although expression of Myc-Miro increased slightly the levels of YFP-Parkin on mitochondria, MiroS156E caused a significantly greater mitochondrial accumulation of Parkin ( Fig. 1 A and B) , and consequently a higher ratio of Parkin to Miro on mitochondria (Fig.  S1C ). This effect cannot be attributed to cross-talk between fluorophores because the accumulation of YFP-Parkin is also apparent in the absence of the second fluorophore (Fig. S1D) . Thus, mimicking phosphorylation of Miro on S156 can recruit Parkin to the mitochondria. To observe with higher detail the recruitment of Parkin to the mitochondria by MiroS156E, we collected stacks of confocal images of a MiroS156E, YFP-Parkin-expressing fibroblast, and performed a 3D reconstruction. We also performed a line scan of the same region from a confocal image (Fig. S1E) . Parkin-YFP signal colocalizes with α-Tom20 signal in the reconstruction and in the line-scan. Because Parkin recruitment to mitochondria is thought to depend on its activation by PINK1 (35), we also examined the effects of MiroS156E expression in primary embryonic fibroblasts from PINK1 −/− rats (47) . MiroS156E caused equivalent mitochondrial localization of YFP-Parkin in these cells (Fig. 1B and Fig. S2) . Thus, the phosphomimetic form of Miro was capable of recruiting Parkin to mitochondria even in the absence of PINK1.
Phosphomimetic Mutant MiroS156E Enhances Mitochondrial
Fragmentation. The mitochondrial network also appeared fragmented in cells where MiroS156E was coexpressed with YFP-Parkin (Fig. 1A) . To quantify this phenotype, we incorporated a particle analysis feature to Mitolyzer1.0 and determined the numbers of small (0.2-5 μm in diameter) and rounded (circularity ∼0.5-1) mitochondria in the fibroblasts. The average number of small rounded mitochondria per cell was ∼50 in control cells, but almost doubled with MiroS156E expression and this effect was equally apparent in PINK1 −/− fibroblasts (Fig. 1C) . Fragmentation also increased significantly when Miro was expressed, although to a lesser extent (∼30% of control). This fragmentation was dependent on Parkin activity because it did not occur when we substituted YFP-ParkinC431F, a catalytically dead form of Parkin that is not recruited to mitochondria (36) . YFP-ParkinC431F was not significantly recruited to mitochondria by MiroS156E and the mitochondrial network was not fragmented by their coexpression ( Fig.  1 A, D, and E). Thus, Myc-MiroS156E, and to a lesser extent MycMiro overexpression, promoted Parkin recruitment to the mitochondria and induced mitochondrial fragmentation as a consequence of the catalytic activity of Parkin, and these effects of MiroS156E did not require additional activation of Parkin by PINK1.
Phosphomimetic MiroS156E Can Arrest Axonal Transport of Mitochondria.
The PINK1/Parkin pathway, by triggering the degradation of Miro, halts the movement of axonal mitochondria (15) . To determine if S156E similarly altered mitochondrial behavior in neurons, we coexpressed Mito-DsRed to label mitochondria, synaptophysin-GFP (Syp-GFP) to label axons, and either Myc-MiroWT or MycMiroS156E in either wild-type or Parkin KO mouse hippocampal neurons (48) . We then imaged live neurons by time-lapse microscopy and calculated the average time mitochondria spent in motion in each condition. Although expression of Miro did not significantly affect mitochondrial motility, expression of MiroS156E diminished the percentage of mitochondria that were moving in either direction (Fig. 1 F and G and Table S1 ). Mitochondrial arrest induced by MiroS156E was specific to mitochondria, as the movement of Syp-GFP vesicles was not altered (Fig. 1G and Table  S1 ). Moreover, in Parkin −/− neurons, expression of MiroS156E failed to induce mitochondrial arrest (Fig. 1 F and G and Table  S1 ). Thus, mimicking PINK1 phosphorylation on S156 induced mitochondrial arrest in a Parkin-dependent manner, similar to the effect of PINK1 activation or overexpression and not through a nonspecific disruption of the transport apparatus.
Phosphomimetic MiroS156E Does Not Induce Mitophagy. When mitochondrial damage causes PINK1 stabilization on the OMM, Parkin-recruitment to mitochondria and mitochondrial fragmentation are a prelude to mitophagy (8) . To assess if mimicking phosphorylation on S156 induced mitophagy, we expressed MycMiro, either wild-type or S156E, along with Parkin in fibroblasts and examined three mitophagy markers: mitochondrial content, mitochondrial α-ubiquitin staining, and colocalization of LC-3 with mitochondria ( Fig. 2) . We also quantified the levels of Parkin recruitment to the mitochondria. We used cells only expressing Miro as a negative control, and cells that overexpressed Parkin and were treated with carbonyl cyanide 3-chlorophenylhydrazone (CCCP) as a positive control. As expected, in CCCPtreated cells, mitochondrial content, as judged by α-Tom20 immunoreactivity, was drastically reduced (Fig. 2C) , and α-ubiquitin immunoreactivity, LC-3, and Parkin colocalization with mitochondria increased (Fig. 2 B and D-F) (49) . In contrast, (Scale bars, 10 μm.) *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. See also Table S1 .
although Myc-MiroS156E coexpression with Parkin increased Parkin and α-ubiquitin colocalization with mitochondria relative to Myc-MiroWT coexpression with Parkin, the S156E mutation did not cause LC-3 recruitment. Miro coexpression with Parkin caused a modest decrease in mitochondrial content, but there was no significant further effect of the S156E mutation. The extent of mitochondrial ubiquitination induced by the S156E mutation presumably reflects Parkin activity, but at levels significantly lower than those induced by CCCP ( Fig. 2 A and D) . Thus, Parkin recruitment and activation by MiroS156E, although sufficient to induce mitochondrial fragmentation, was inadequate to trigger the full pathway for mitophagy; PINK1 activity on other substrates, such as ubiquitin and Parkin itself, is probably needed for mitophagy to proceed.
Miro Phosphomimetic S156E Promotes the Interaction of Parkin with
Miro. To explore the mechanism underlying MiroS156E-induced Parkin recruitment, we turned to established cell lines. When wild-type Miro (Myc-Miro) was coexpressed with Parkin and HA-ubiquitin in HeLa cells and the PINK1/Parkin pathway was activated by CCCP, Miro immunoreactivity appeared in higher molecular-mass bands than that of 75 kDa unmodified Myc-Miro (Fig. S3A ). When we immunoprecipitated Myc-Miro, the high molecular-mass bands were positive for both α-Myc and α-HAubiquitin. Thus, Parkin-induced ubiquitination of Myc-Miro can be detected as α-Myc + bands migrating more slowly than 75 kDa. The apparent synergism of CCCP, an activator of PINK1, and Parkin-expression in promoting Miro ubiquitination could be because of PINK1 phosphorylation of either Parkin or Miro or both. Therefore, to examine the contribution of phosphorylation of MiroS156 we compared phosphoresistant Myc-MiroS156A (where Serine 156 was changed to Alanine) to Myc-Miro. Several groups have failed to detect differences in Myc-MiroS156A ubiquitination levels compared with Myc-Miro (44, 50) . In agreement with these groups, we also see that, under some circumstances, Myc-MiroS156A high molecular-mass bands can be induced by Parkin (Fig. S3B) . Our results indicate that in conditions where Parkin is strongly activated, the status of S156 is of lesser importance. However, if levels of Parkin activity are moderate to low, as in the following experiments, the phosphorylation status of S156 can determine the extent of Miro ubiquitination and degradation. After coexpression of either Myc-Miro or S156A with either PINK1 or Parkin in HEK cells, the Myc-Miro band had significantly less immunoreactivity compared with Myc-MiroS156A (Fig. 3 A and B) , suggesting that phosphorylation on S156 indeed facilitates Miro degradation. The efficacy of the phosphoresistant mutation in also preserving Miro levels in the absence of PINK1 overexpression or activation with CCCP suggests that this site may Background-subtraction and normalization to MBP levels as in J. *P < 0.05, **P < 0.01, **** P < 0.0001.
undergo phosphorylation even in their absence. If CCCP was used to activate the endogenous PINK1/Parkin pathway, the influence of the S156 site was also apparent. When we transfected low levels of Myc-Miro or Myc-MiroS156A in HEK293T and treated the cells with CCCP for 1 h before lysis, Myc-Miro underwent more proteasome-dependent degradation than Myc-MiroS156A ( Fig. 3  C and D) . To test the significance of S156 for ubiquitination of Miro, either wild-type or MiroS156A was expressed together with Parkin and HA-ubiquitin in HEK293T cells and Miro was immunoprecipitated with α-Myc. Myc-MiroS156A had less anti-HA-ubiquitin immunoreactivity than Myc-Miro (Fig. 3E) . We then asked if phosphorylation stimulated the interaction of Miro with Parkin. We coexpressed Miro and Parkin, immunoprecipitated Miro with α-Myc, and then treated the immunoprecipitate with calf alkaline phosphatase (CIP). The interaction of Miro with Parkin was significantly weaker upon the treatment with the phosphatase (Fig. 3 F and G) , Thus, Miro-Parkin interaction is promoted by phosphorylations. To test if the interaction depended on Miro phosphorylated on S156, we coexpressed either Myc-Miro or MycMiroS156A with YFP-Parkin in HEK293T cells and examined the amount of Parkin coprecipitated with Miro. Less YFP-Parkin coprecipitated with Myc-MiroS156 than with Myc-Miro ( Fig. 3 G and H), and Myc-MiroS156A also had significantly less of the slowly migrating and presumably ubiquitinated bands ( Fig. 3 H and  I) . Thus, the interactions of Parkin with Miro in HEK293T cells depend, at least in part, on phosphorylation of Miro on S156.
The effects of the S156A mutation suggested that phosphorylation of this site promotes Parkin-Miro interactions. To test this hypothesis directly, we affinity-purified recombinant human Parkin tagged with maltose binding protein (MBP) (Fig. S3C) , which is catalytically active (Fig. S3D) , and incubated it with wild-type and phosphomimetic forms of bacterially expressed Miro. Because recombinant Drosophila Miro can be successfully expressed and purified, we used Drosophila Miro with glutamate or aspartate substitutions at S182 (dMiroS182E or -D), the site equivalent to mammalian S156. After incubation of the proteins for 30 min at 37°C, we immunoprecipitated MBP-Parkin and evaluated the levels of dMiro present in the precipitate. The interaction was significantly greater for dMiroS182E and dMiro182D than for dMiroWT ( Fig. 3  K and L and Fig. S3E ). Collectively, these lines of evidence suggested that Miro phosphorylation on S156 promotes the ubiquitination and degradation of Miro by stimulating its interaction with Parkin.
Miro T298E and T299E Phosphomimetics Render Miro Resistant to
Parkin-Induced Ubiquitination and Degradation. To determine the consequences of phosphorylation of T298 and T299, we replaced both residues with a phosphomimetic glutamate (Miro298/9EE) mutant. We also generated a triple Miro phosphomimetic mutant (MiroEEE = MiroS156E,T298E,T299E). The mutations did not affect the ability of Miro to localize to mitochondria or bind to Milton (Fig. S1 ). Although we anticipated that coexpression of the mutants with YFP-Parkin would promote the slower-migrating and presumably ubiquitinated bands of Miro similar to S156E, Miro298/9EE, and MiroEEE, mutants were resistant to the modification (Fig. 4 A and B) , even at high ratios of Parkin:Miro transfection (Fig. 4 C and D) . Moreover, Parkin expression conditions that caused wild-type Miro levels to be significantly reduced did not reduce levels of MiroEEE (Fig. 4 E and F) . We confirmed that the slower-migrating bands of MiroWT and S156E were immunoreactive for HA-ubiquitin but no HA-ubiquitin was observed in the immunoprecipitate when MiroEEE was coexpressed with Parkin (Fig. S4) . Thus, mimicking phosphorylation on T298 and T299 likely suppresses the ubiquitination and degradation of Miro by Parkin and does so even when S156 also has been replaced by a glutamate. However, PINK1 activation of Parkin upon depolarization of mitochondria with CCCP could override the effect of T298/9EE; Miro levels were reduced and the slower-migrating Miro bands appeared, consistent with ubiqutination (Fig. 4G) . The effect of Miro phosphomimetic mutations thus depends on the level of Parkin activation.
MiroT298E,T299E Inhibits Parkin Effects on Mitochondrial Dynamics.
The partial resistance of MiroEEE mutants to degradation in cell lines suggested that 298/9EE might also suppress the effects of Parkin on mitochondrial dynamics. In primary rat fibroblasts, Miro298/9EE prevented S156E from recruiting Parkin; the triple phosphomimetic induced neither mitochondrial accumulation of Parkin nor fragmentation (Fig. 5 A-C) . Consistent with these findings, the 298/9EE mutant also suppressed the effect of S156E on mitochondrial movement in axons; neither Myc-Miro298/9EE nor EEE arrested their transport (Fig. 5 D and E and Table S2 ).
To test the effects of 298/9EE on mitochondrial dynamics when endogenous PINK1 was activated, we transfected rat hippocampal neurons with either with Myc-Miro or Myc-Miro298/9EE and applied 10 μM antimycin A to activate the PINK1/Parkin pathway (51) . Antimycin A caused mitochondrial arrest in both populations (Fig. 5G) , although a low amount of axonal mitochondrial movement was visible in Miro298/9EE-expressing neurons at late timepoints (Fig. 5 F and G and Table S3 ) that was significantly higher than in control neurons expressing Myc-Miro. This experiment indicated that even upon depolarization, the presence of the 298/ 9EE mutation can modestly delay the onset of Parkin activity with regard to Miro. Therefore, we concluded that the presence of a phosphate-mimicking modification on T298 and T299 can, via the suppression of Miro ubiquitination and degradation, negatively regulate the ability of Parkin to regulate mitochondrial dynamics.
Discussion
The physiological role of PINK1 modification of Parkin substrates has been unclear. We report here that: (i) mimicking phosphorylation of the Parkin substrate Miro at S156 can recruit Parkin to mitochondria; (ii) Parkin can be activated by phosphomimetic Miro in a PINK1-null background; (iii) substrate-based activation of Parkin can cause mitochondrial fragmentation and mitochondrial arrest, but will not proceed to mitophagy without PINK1 activation of Parkin; and (iv) the effect of the modification of S156 is reversible by phosphomimetic substitutions on two other Miro residues.
Solving how PINK1 recruits Parkin to damaged mitochondria will be instrumental for the rational design of Parkin-modulatory therapies. Besides modifying ubiquitin and Parkin, PINK1 phosphorylates several known Parkin substrates on the mitochondrial outer membrane. Phosphorylation-dependent recruitment of E3 ligases to their substrates is a common regulatory theme (52) , and we propose that Parkin is no exception to this pattern. To circumvent PINK1 phosphorylation of Parkin and isolate the consequences of the substrate phosphorylation, we used phosphomimetic substitutions either in wild-type fibroblasts where PINK1 was not activated pharmacologically or in rat embryonic fibroblasts lacking PINK1, where even background activity of the kinase would be lacking. In either case, mimicking PINK1 phosphorylation of Miro on S156 promoted Parkin recruitment to mitochondria in fibroblasts ( Fig. 1 A and B and Fig. S2 ). In vitro, mimicking this modification enhanced the interaction of Miro with Parkin ( Fig. 3 K and  L and Fig. S3E) . Thus, the phosphorylation state of a Parkin substrate can stimulate Parkin interaction with that substrate and was sufficient to recruit Parkin to the mitochondria. In neurons, the cell type most affected by pathological mutations in PINK1 and Parkin, mimicking S156 phosphorylation was sufficient to cause Parkindependent arrest of mitochondria (Fig. 1 F and G) , indicating that the S156E modification can stimulate endogenous Parkin. Substrate phosphorylation has also been reported to cause Mitofusin1/2 degradation upon Parkin recruitment (41) , and thus may influence a variety of Parkin targets. Because Parkin-mediated degradation of Miro and Mitofusin1/2 happens before bulk clearance of mitochondrial proteins by mitophagy (15) , selective phosphorylationpromoted recruitment of Parkin to particular high-priority targets may play a role in the early steps of Parkin recruitment, whereas ubiquitin phosphorylation is instrumental in driving the subsequent feed-forward loop that broadly ubiquitinates many proteins at the mitochondrial surface and induces mitophagy. Table S3 .
What role, if any, does PINK1 modification of Parkin substrates play in regulating the catalytic activity of Parkin? Parkin is a selfinactivated enzyme whose activity is stimulated by two PINK1 phosphorylations: (i) phosphorylation of S65 in the ubiquitin-like domain of Parkin and (ii) phosphorylation of an equivalent serine in ubiquitin, which can allosterically activate Parkin. Our data indicate that PINK1 phosphorylation of Miro also can activate Parkin, even in the absence of the other two events. Overexpression of wild-type Miro itself could cause Parkin to translocate to mitochondria, but the effect was enhanced by the phosphomimetic mutation ( Fig. 1 A  and B) . The action of the phosphorylation, therefore, is less like an on/off switch than like an increase in the affinity for Parkin, and hence an increase in its ability to activate Parkin. Because Parkin catalytic activity is needed for Parkin to remain on mitochondria after mitochondrial depolarization (36, 53) , Parkin recruitment to mitochondria can be used as a proxy for Parkin activity. Consistent with activation of Parkin by the MiroS156E phosphomimetic, wildtype Parkin, but not catalytically inactive Parkin, accumulated on mitochondria. Further evidence for catalytic activation of Parkin by Miro S156E was the fragmentation of the mitochondrial network upon its coexpression with Parkin in fibroblasts, a phenotype that also did not occur when the catalytically dead Parkin was expressed ( Fig. 1 A and B) . Importantly, PINK1 was not needed in these experiments, as we observed the same phenotypes in PINK1-null cells (Fig. S2) . Thus, PINK1 phosphorylations of ubiquitin or Parkin are not absolutely required for Parkin activation. It will be interesting to know if substrate-driven activation is specific to Miro or can extend to other Parkin substrates as well.
Although PINK1 phosphorylation of S156 is supported both by previous data from our laboratory and the functional experiments presented here, other groups have failed to observe a role of PINK1-induced S156 phosphorylation in the ubiqutination of Miro (44, 50) . One reason for the disparity may lie in the high levels of Parkin used in these experiments. In agreement with those studies, we also find that nonphosphorylatable Miro gets ubiquitinated by Parkin in those conditions (Fig. S3B) . However, in those experiments where only endogenous Parkin was present, we observe a clear effect of the S156A mutation (Fig. 3 A, and C and D) . Therefore, although PINK1-mediated S156 phosphorylation is not required for Miro degradation, the functional effect of mutating this site can be revealed when Parkin activity is low to moderate. The in vivo significance of the phosphorylation site was observed in Drosophila (46) and is also supported by our previous observations on mitochondrial motility in hippocampal neurons (15) .
Once Parkin has been recruited to Miro, it could have access to other mitochondrial substrates. The fragmentation of mitochondria we observed in MiroS156E could, for example, reflect the secondary loss of proteins that support fusion (39, 41, 54) , although it might also be because of the loss of kinesin from mitochondria when Miro is degraded (55) . However, MiroS156E recruitment of Parkin did not induce detectable mitophagy, at least in the time frame that we analyzed (Fig. 2) . Therefore, PINK1 modification of this single substrate, although able to recruit Parkin to Miro and even to activate Parkin for Miro ubiquitination, was not sufficient to induce the widespread ubiquitination of proteins on the mitochondrial surface, and thereby cause the recruitment of adaptor proteins and mitophagy (29, 30, 36, 56, 57) . When PINK1 is activated in the context of mitochondrial damage, it will act on multiple targets, including Parkin and ubiquitin, and thereby achieve full enzymatic activity of Parkin and trigger mitophagy.
The possibility of limited activation of the PINK1/Parkin pathway offers a potential mechanism to separate mitochondrial arrest from mitophagy: some PINK1 and Parkin substrates, including Miro and Mitofusin1/2 (26, 39) , may undergo proteasomal degradation rather than autophagic degradation because of their special relationship with PINK1 and Parkin. We do not know whether the degradation of Miro in mammalian cells under normal physiological conditions is always an early "pro-clearance" step in a series that will ultimately produce mitophagy, or if there are levels of PINK1 activation that will stop the process with Miro degradation and a decrease in mitochondrial motility. In Drosophila, however, alterations in mitochondrial motility can be seen with manipulations of PINK1 and Parkin that do not appear to involve widespread mitophagy (15, 46, 58) . If Miro degradation is a step toward clearance of either a segment of the OMM or mitophagy of the entire organelle (8, 59) , it is likely to be important, along with Mitofusin1/2 degradation, as a means to quarantine damaged mitochondria rapidly before the slower steps of autophagosome-dependent mitophagy or mitochondria-derived vesicle-based quality control.
To our surprise, phosphomimetic modifications on T298 and T299 acted in an opposite manner to S156. The physiological significance of these sites is currently less clear. There is uncertainty at present concerning the kinase that acts at these sites in vivo; it may not be PINK1. However, the unexpected finding that phophomimetics at these residues can prevent the effects of S156 phosphorylation raises the possibility that they are part of a negative regulatory pathway requiring further exploration.
Better understanding of the regulation of Parkin by PINK1 may lead to rational strategies for treating Parkinson's disease. Although many studies have focused on Parkin and ubiquitin phosphorylation by PINK1, our findings highlight the need to consider also the role that PINK1 substrates like Miro play in the onset of Parkin activity. The PINK1/Parkin mechanism now appears more complex and can involve proteasomal degradation of specific substrates as well as lysosomal clearance of either all or part of a mitochondrion. Because Parkin can be activated and recruited or inhibited by substrate phosphorylations, the state of particular substrates may influence the end results of the pathway.
Materials and Methods
Reagents. Myc-Miro mutants were generated by mutagenizing Myc-Miro plasmid (60) with a QuikChange Site Directed Mutagenesis Kit (Agilent). YFP-ParkinC431F mutant was generated as above using YFP-Parkin (8) In Vitro Experiments, Immunoprecipitations, and Western Blotting. dMiro constructs were mutagenized using standard procedures and then expressed in bacteria, purified, and stored as described in ref. Statistical Analysis. All statistical analyses were performed using GraphPad Prism v6.0. All samples were first subjected to a D'Angostino-Pearson omnibus normality test. If values came from a Gaussian distribution, t-test analysis was used for paired comparisons and one-way ANOVA along with Bonferroni correction for multiple comparisons. If values came from a non-Gaussian distribution, a Mann-Whitney U test was used for paired comparisons and Kruskall-Wallis nonparametric ANOVA test was used for multiple comparisons. Graph bars represent the mean ± SEM P values: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
